AU2001231987A1 - Polyanionic polyglycosides in the treatment of autism - Google Patents

Polyanionic polyglycosides in the treatment of autism

Info

Publication number
AU2001231987A1
AU2001231987A1 AU2001231987A AU3198701A AU2001231987A1 AU 2001231987 A1 AU2001231987 A1 AU 2001231987A1 AU 2001231987 A AU2001231987 A AU 2001231987A AU 3198701 A AU3198701 A AU 3198701A AU 2001231987 A1 AU2001231987 A1 AU 2001231987A1
Authority
AU
Australia
Prior art keywords
autism
treatment
polyanionic
polyglycosides
polyanionic polyglycosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231987A
Inventor
Stephen Dealler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of AU2001231987A1 publication Critical patent/AU2001231987A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2001231987A 2000-02-11 2001-01-29 Polyanionic polyglycosides in the treatment of autism Abandoned AU2001231987A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0003048 2000-02-11
GBGB0003048.6A GB0003048D0 (en) 2000-02-11 2000-02-11 The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
PCT/GB2001/000344 WO2001058456A1 (en) 2000-02-11 2001-01-29 Polyanionic polyglycosides in the treatment of autism

Publications (1)

Publication Number Publication Date
AU2001231987A1 true AU2001231987A1 (en) 2001-08-20

Family

ID=9885309

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001231987A Abandoned AU2001231987A1 (en) 2000-02-11 2001-01-29 Polyanionic polyglycosides in the treatment of autism
AU2001232031A Abandoned AU2001232031A1 (en) 2000-02-11 2001-02-09 Novel uses of polyanionic polyglycosides in treating gut disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001232031A Abandoned AU2001232031A1 (en) 2000-02-11 2001-02-09 Novel uses of polyanionic polyglycosides in treating gut disorders

Country Status (4)

Country Link
US (2) US20010039265A1 (en)
AU (2) AU2001231987A1 (en)
GB (1) GB0003048D0 (en)
WO (2) WO2001058456A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
JP4335005B2 (en) * 2001-10-18 2009-09-30 生化学工業株式会社 Inflammatory bowel disease treatment
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
IT1397247B1 (en) * 2009-05-14 2013-01-04 Fidia Farmaceutici NEW REGULATORY AGENTS OF CYTOKINIC ACTIVITY
KR20180107341A (en) * 2017-03-16 2018-10-02 차의과학대학교 산학협력단 Composition for the treatment and prevention of Leaky Gut Syndrome comprising Potassium-Competitive Acid Blocker as active component

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
US5580858A (en) * 1991-06-10 1996-12-03 Alberta Research Council Immunosuppressive and tolerogenic modified Lewisx compounds
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
UA72189C2 (en) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Aqueous suspensions of 9-hydroxy-risperidone fatty acid esters provided in submicron form
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine

Also Published As

Publication number Publication date
WO2001058457A1 (en) 2001-08-16
WO2001058456A1 (en) 2001-08-16
US20010056078A1 (en) 2001-12-27
AU2001232031A1 (en) 2001-08-20
US20010039265A1 (en) 2001-11-08
GB0003048D0 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2020501A (en) Chemotherapy treatment
AU2001239975A1 (en) Least choice first arbiter
AU2002224553A1 (en) Human proteases
AU2001268525A1 (en) Human kinases
AU2001238488A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2001277959A1 (en) Human kinases
AU2001260834A1 (en) The treatment of herpes
AU2001241910A1 (en) Distributed least choice first arbiter
AU2001231987A1 (en) Polyanionic polyglycosides in the treatment of autism
AU2001236929A1 (en) Surface treatment
AU2001253521A1 (en) Haplotypes of the cxcr4 gene
AU2002327100A1 (en) Member excellent in antibacterial and/or antialgae effects and process for producing the same
AU2002227352A1 (en) Human kinases
AU2001255573A1 (en) Human kinases
EP1201403A3 (en) Electrofusible units
AU2001282349A1 (en) Fluid treatment
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2001257100A1 (en) Nalpha, nomega-dialkyl aminomethylenephosphonic acids and use thereof
AU2001292027A1 (en) Methods relating to polymorphisms in the human gpr10 gene
AU2001240017A1 (en) Human enzyme molecules
AU2001272440A1 (en) Glass body
GB0027809D0 (en) The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
AU2001255330A1 (en) Haplotypes of the akr1b1 gene